Recursion Pharmaceuticals CEO Chris Gibson goes one-on-one with Jim Cramer

Поділитися
Вставка
  • Опубліковано 6 вер 2024
  • Recursion Pharmaceuticals Co-Founder and CEO Chris Gibson joins 'Mad Money' host Jim Cramer to talk integrating machine learnings into drug development and partnering with Nvidia.

КОМЕНТАРІ • 24

  • @stevecrombie8421
    @stevecrombie8421 3 місяці тому +5

    I’m backing the guy.

  • @JimMcNutty
    @JimMcNutty 3 місяці тому +1

    Throwing around NVDA gives street cred to anyone.

  • @ppandit7091
    @ppandit7091 3 місяці тому +8

    This Gibson fellow is selling stock left right and center. These CEOs lie through their teeth.

    • @Jsinghca7
      @Jsinghca7 Місяць тому

      Thanks man for the news.
      I was about to invest in this cheap stock.

  • @ThelmaMonson-u5j
    @ThelmaMonson-u5j 5 днів тому

    Perez Shirley Harris Patricia Garcia Michael

  • @Orbitaonamika
    @Orbitaonamika 12 днів тому

    Harris Melissa Miller Michael Lee Deborah

  • @dylkabrooks1458
    @dylkabrooks1458 2 дні тому

    Martin Matthew Allen William Rodriguez Elizabeth

  • @junserafin5241
    @junserafin5241 3 місяці тому +1

    Most people don't have the patience for something like this.
    It's not a get rich quick stock.
    Look at $LLY 15 or even 10 years ago and the price now
    $NVDA was under $1 in 2001. $REGN etc..❤🎉

  • @PaulaNguyen-d9w
    @PaulaNguyen-d9w День тому

    Lewis Gary Martinez George Martinez Carol

  • @FullToki
    @FullToki 4 дні тому

    Johnson Helen Lee Thomas Gonzalez Edward

  • @EdwardHernandez-l4z
    @EdwardHernandez-l4z 5 днів тому

    Martinez Larry Johnson Carol Harris Nancy

  • @FunnySorry-p9c
    @FunnySorry-p9c 2 дні тому

    Gonzalez Carol Miller Karen Thomas Matthew

  • @FannyAntonia-g2l
    @FannyAntonia-g2l 3 дні тому

    Perez Carol Walker Thomas Thompson Betty

  • @DanaHenderson-l2e
    @DanaHenderson-l2e 10 днів тому

    Jackson Susan Lee Sandra Lee Brenda

  • @FreemanCoral
    @FreemanCoral 3 дні тому

    Wilson William Jackson Kenneth Smith Susan

  • @NextLevel-hr8wp
    @NextLevel-hr8wp 2 місяці тому +1

    AI bubble is bursting because RXRX's inability to secure investors reveals a lack of confidence in AI-driven biotech claims. Who is next? He said they would not dilute, yet one month later, they did a $200 million Class A offering. the CEO sold too 90 time. Nvidia invested in RXRX-was it a mistake or an AI failure? AI promised to accelerate results, but so far, it's just burning cash with no product ready for market. Nvidia benefits from selling their AI Shovel, but if RXRX's product doesn't deliver, what's the purpose of buying more from Nvidia?

  • @keithb372
    @keithb372 3 місяці тому +1

    Not interested.

  • @EricColter-j4p
    @EricColter-j4p 5 днів тому

    Smith Mary Garcia Kevin Williams Michelle

  • @dereksekeatase630
    @dereksekeatase630 4 дні тому

    Martinez Maria Lee Donald Thompson Maria

  • @YuleTaylor-l8g
    @YuleTaylor-l8g 4 дні тому

    Thomas Sharon Jones Amy Brown Ronald

  • @JklZxc-b4u
    @JklZxc-b4u 4 дні тому

    Anderson Brenda Perez Susan Young Richard

  • @HjkBn-l7c
    @HjkBn-l7c 2 дні тому

    Williams John Jackson Carol Gonzalez Jason